Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
IgA nephropathy (IgAN) is the most common glomerulonephritis, and about 20-40% of the patients were developing end-stage kidney disease at 20 years after kidney biopsy. The pathogenesis of the disease is still unclear, although the full extent of the disease needs to be clarified as soon as possible.In the present study, we designed a study focusing on the 'intestinal-renal association' to elucidate the pathogenesis of IgAN. Since most cases of IgAN progress to chronic kidney disease, we first analyzed the intestinal microbiota of patients with chronic kidney disease to determine its distribution.In addition, serum cytokines associated with the intestinal microbiota have been measured in patients with chronic kidney disease and are currently being analyzed.
|